Trimetazidine is an anti-anginal and metabolic modulator used to manage chronic stable angina. It works by improving the heart muscle’s energy efficiency during low oxygen supply, helping reduce chest pain and enhance exercise tolerance. Unlike traditional heart medicines that affect heart rate or blood pressure, Trimetazidine protects heart cells from damage during oxygen deprivation. Regular use helps maintain better cardiac function, particularly in patients with long-standing coronary artery disease.

Trimetazidine is a prescription medicine used for the long-term management of chronic stable angina. It belongs to the group of metabolic anti-ischaemic agents that improve how heart muscle cells utilise oxygen. Unlike nitrates, beta-blockers, or calcium channel blockers, which directly influence heart rate or blood pressure, Trimetazidine acts at the cellular level by optimising energy metabolism. It promotes the shift from fatty acid oxidation to glucose oxidation, a more efficient energy pathway during episodes of reduced blood flow to the heart. This enhances the heart’s resistance to ischaemia, reduces the frequency of angina attacks, and helps patients perform daily activities with fewer symptoms.

Trimetazidine 80 mg is generally prescribed as part of combination therapy for angina, especially when first-line medicines alone do not adequately control symptoms. It supports long-term cardiac stability and may help reduce the chances of chest pain triggered by physical exertion, stress, or cold weather. The medicine does not significantly affect blood pressure or pulse rate, making it suitable for patients who cannot tolerate haemodynamic changes caused by other anti-anginal drugs.

Regular use is essential for maintaining therapeutic benefits, as Trimetazidine works cumulatively over time rather than providing immediate relief of acute chest pain. Patients should continue taking the medicine as prescribed and should not discontinue it abruptly without medical advice. For optimal cardiac protection, Trimetazidine should be used alongside lifestyle modifications, such as a heart-healthy diet, controlled exercise, smoking cessation, and regular monitoring of cardiovascular risk factors.

• Management of chronic stable angina
• Reducing the frequency of angina attacks
• Improving exercise tolerance in angina patients
• Supporting heart cell function during low oxygen supply (ischaemia)
• Adjunct therapy when standard anti-anginal medicines do not adequately control symptoms

1. Enhances Heart Energy Efficiency

Trimetazidine improves the metabolic functioning of heart cells, helping them produce energy more efficiently during reduced blood flow. This protects the heart from ischaemia-related damage.

2. Reduces Frequency of Angina Attacks

With regular use, it decreases chest pain episodes and stabilises symptoms, making daily activities easier and more comfortable.

3. Suitable for Patients Unsuitable for Other Angina Medicines

Since Trimetazidine does not significantly impact heart rate or blood pressure, it can be used in patients who are intolerant to traditional anti-anginal drugs.

• Nausea or vomiting
• Indigestion or stomach discomfort
• Dizziness
• Headache
• Fatigue
• Skin rash (rare)
• Movement disorders such as tremors or rigidity (very rare)
• Sleep disturbances Stop taking Trimetazidine and seek medical help if you experience abnormal movements, severe dizziness, or allergic reactions.

• Take Trimetazidine as prescribed by your doctor.
• Swallow the tablet whole with a glass of water.
• Usually taken twice daily or as directed.
• Do not chew or crush the tablet.
• Take at the same time each day for consistent relief.
• Continue even if symptoms improve unless advised otherwise.

Trimetazidine works by modifying the metabolic processes of heart cells during periods of oxygen shortage. Normally, the heart utilises fatty acids for energy, a process that requires more oxygen. Trimetazidine shifts the energy production pathway towards glucose oxidation, which is more oxygen-efficient. This optimises the energy supply to heart cells, reduces lactic acid buildup, and prevents intracellular acidosis. As a result, the heart muscle maintains better function even during ischaemia, helping reduce the frequency and severity of angina attacks. It does not alter blood pressure or heart rate, making it safer for patients with haemodynamic instability. Over time, this metabolic protection enhances cardiac endurance and overall symptom control.

• Take the medicine regularly for best results; it does not offer immediate relief.
• Do not use Trimetazidine to treat sudden chest pain. Use doctor-prescribed rescue medication instead.
• Inform your doctor if you notice tremors, stiffness, or unsteady movements.
• Maintain a healthy heart lifestyle for optimal benefit.
• Avoid abrupt discontinuation without medical advice.

• Store in a cool, dry place away from heat and moisture.
• Keep the blister sealed until use.
• Keep out of reach of children and pets.
• Do not use expired tablets; discard safely according to local guidelines.

Trimetazidine can be taken with or without food. However, taking it after meals may help reduce nausea or stomach discomfort.

Avoid:

• Excessive alcohol, which can worsen dizziness

• High-fat heavy meals that may stress cardiac metabolism

There are no major food interactions, but maintaining healthy dietary habits is essential for angina management.

Some medications may interact with Trimetazidine, increasing side effects or reducing effectiveness. Always inform your doctor about all the medicines you are taking.

Possible interactions with:

• Medicines causing drowsiness: May increase dizziness
• Parkinson’s disease medicines: Symptoms may worsen
• Certain antidepressants: Increased risk of tremors
• Antihistamines: May enhance sedation Although major interactions are uncommon, monitoring is essential in elderly patients.

Trimetazidine should be used cautiously in certain medical conditions. Discuss your full medical history with your doctor before starting treatment. Use with caution in:

• Parkinson’s disease
• Movement disorders
• Severe kidney impairment
• Elderly patients (higher risk of neurological side effects)
• Severe liver disease Patients with active movement disorders should avoid Trimetazidine due to rare but serious adverse neurological reactions.

The typical dose is one 80 mg prolonged-release tablet taken twice daily or as directed by your cardiologist. Do not exceed the prescribed dose. Continue long-term therapy for stable control of angina symptoms.

Taking more than the prescribed dose may cause severe dizziness, nausea, headaches, or movement disorders. Seek immediate medical attention. Supportive care may be required.

If you miss a dose, take it as soon as you remember. If it is nearly time for your next dose, skip the missed dose and continue with your regular schedule. Do not take extra tablets to make up for a forgotten dose. Maintaining a consistent dosing routine is important for optimal angina control, so consider setting reminders.